Blair William & Co. IL increased its position in shares of Xylem Inc. (NYSE:XYL - Free Report) by 17.6% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 48,600 shares of the industrial products company's stock after purchasing an additional 7,269 shares during the quarter. Blair William & Co. IL's holdings in Xylem were worth $6,287,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also bought and sold shares of the company. Price T Rowe Associates Inc. MD lifted its holdings in shares of Xylem by 689.5% in the first quarter. Price T Rowe Associates Inc. MD now owns 3,708,963 shares of the industrial products company's stock worth $443,074,000 after acquiring an additional 3,239,203 shares during the last quarter. Nuveen LLC bought a new position in shares of Xylem in the first quarter worth about $99,726,000. OVERSEA CHINESE BANKING Corp Ltd lifted its holdings in shares of Xylem by 390.5% in the first quarter. OVERSEA CHINESE BANKING Corp Ltd now owns 1,021,337 shares of the industrial products company's stock worth $122,009,000 after acquiring an additional 813,100 shares during the last quarter. Vaughan Nelson Investment Management L.P. bought a new position in shares of Xylem in the first quarter worth about $89,828,000. Finally, Swedbank AB lifted its holdings in shares of Xylem by 13.9% in the second quarter. Swedbank AB now owns 4,366,932 shares of the industrial products company's stock worth $564,906,000 after acquiring an additional 531,890 shares during the last quarter. Institutional investors own 87.96% of the company's stock.
Xylem Stock Performance
NYSE XYL opened at $144.30 on Monday. The company has a market cap of $35.12 billion, a P/E ratio of 37.48, a PEG ratio of 2.49 and a beta of 1.13. The company has a fifty day simple moving average of $143.08 and a 200 day simple moving average of $130.45. The company has a current ratio of 1.90, a quick ratio of 1.43 and a debt-to-equity ratio of 0.17. Xylem Inc. has a 12-month low of $100.47 and a 12-month high of $151.16.
Xylem (NYSE:XYL - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The industrial products company reported $1.26 EPS for the quarter, beating analysts' consensus estimates of $1.15 by $0.11. The business had revenue of $2.30 billion during the quarter, compared to analyst estimates of $2.20 billion. Xylem had a net margin of 10.74% and a return on equity of 10.33%. Xylem's quarterly revenue was up 6.1% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.09 EPS. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. Sell-side analysts predict that Xylem Inc. will post 4.65 earnings per share for the current fiscal year.
Xylem Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Thursday, August 28th were paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 1.1%. The ex-dividend date was Thursday, August 28th. Xylem's payout ratio is 41.56%.
Insider Buying and Selling
In other Xylem news, CAO Geri-Michelle Mcshane sold 1,000 shares of the firm's stock in a transaction on Friday, September 5th. The stock was sold at an average price of $139.96, for a total transaction of $139,960.00. Following the transaction, the chief accounting officer directly owned 2,957 shares in the company, valued at approximately $413,861.72. This trade represents a 25.27% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.27% of the company's stock.
Wall Street Analysts Forecast Growth
A number of research firms have recently commented on XYL. Weiss Ratings reissued a "buy (b)" rating on shares of Xylem in a report on Wednesday, October 8th. Mizuho increased their target price on shares of Xylem from $125.00 to $140.00 and gave the stock a "neutral" rating in a report on Friday, September 12th. UBS Group raised their price objective on shares of Xylem from $164.00 to $168.00 and gave the company a "buy" rating in a report on Tuesday, August 5th. Barclays initiated coverage on shares of Xylem in a report on Friday, September 19th. They issued an "overweight" rating and a $165.00 price objective for the company. Finally, Stifel Nicolaus raised their price objective on shares of Xylem from $162.00 to $175.00 and gave the company a "buy" rating in a report on Friday, August 1st. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and five have given a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $154.67.
Read Our Latest Stock Analysis on Xylem
About Xylem
(
Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
See Also
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report